CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge
Oncology Research · 2025 · 33 (11) · 3375-3385
DOI: 10.32604/or.2025.071708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Xuejun Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Puyang Oilfield General Hospital Affiliated to Henan Medical University, Puyang, 457001, China. Hauptthemen laut MEDLINE: CD47 Antigen, Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Puyang Oilfield General Hospital Affiliated to Henan Medical University, Puyang, 457001, China.
- Puyang Cell Therapy Engineering Technology Research Center, Puyang, 457001, China.
- China Medical University-the Queen's University of Belfast Joint College, Shenyang, 110112, China.
- Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, 3012, Switzerland.
- Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, Sioux Falls, SD 57104, USA.
- Department of Medicine, Sanford Stem Cell Institute, Moores Cancer Center, University of California San Diego, La Jolla, San Diego, CA 92093, USA.
Zitieren
APA
Guo, X., Fu, Y., Baran, N., & Ma, W. (2025). CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge. Oncology Research, 33(11), 3375-3385. https://doi.org/10.32604/or.2025.071708
Vancouver
Guo X, Fu Y, Baran N, Ma W. CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge. Oncology Research. 2025;33(11):3375-3385. doi:10.32604/or.2025.071708
BibTeX
@article{Guo2025,
author = {Guo, Xuejun and Fu, Yilin and Baran, Natalia and Ma, Wenxue},
title = {CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge},
journal = {Oncology Research},
year = {2025},
volume = {33},
number = {11},
pages = {3375--3385},
doi = {10.32604/or.2025.071708}
}
EUVIMED